The best way to avoid lung cancer is to never pick up the smoking habit. Unfortunately, that's no guarantee for skirting deadly lung cancer disease.

Even though someone has quit smoking, he or she still has an elevated risk of developing lung cancer. New research has discovered a common drug may decrease some of those risks.

Lung cancer is most commonly detected with a chest X-ray. This standard technique misses a number of early cancers, though. A study shows another technology is not only a better screening tool, but can save the lives of smokers.

Advanced lung cancer offers few options for patients, unfortunately. A recent Spanish study opens new possibilities by extending the use of an established treatment drug, Alimta.

Advancements in medicine are moving toward targeted therapy - treatments that target the exact cause of an individual's cancer. These advancements are being tested in advanced lung cancer.

Targeted therapy goes after the specific driver of an individual's cancer - a gene, a protein or surrounding tissue. A new drug delivers dramatic results in targeting lung cancer.

A new report says Asian patients live longer than Caucasian patients both before and after the treatment for non-small cell lung cancer (NSCLC), which is usually caused by smoking. A recent review of 35 years of studies indicates that during single, double or triple drug chemotherapy, Asians have a longer overall survival.

Terror, panic and worries raises blood pressure. And that's just what the millions of people in this country living with high blood pressure felt last year. Today, they can take a long sigh. 

Did you know that tobacco will kill 6 million people around the world this year? And by 2030, that number will be 8 million. The World Health Organization (WHO) is leading the fight against this epidemic.

The Marlboro man's rugged, macho cowboy image certainly did sell a lot of cigarettes. He had men thinking, "Let's move to Austin, get on a horse and buy some cigarettes."